Cellular Hypersensitivity To Mitomycin C C5139183
A condition where cells show heightened response to mitomycin C, a chemotherapy agent. This hypersensitivity may affect cancer treatment planning and requires careful medical consideration.
Key facts at a glance
- ICD-10
- Q89.9
- ICD-11
- LA00.0
- Body system
- other
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Severe bone marrow suppression
Mucositis
Generalized symptoms
(other)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Renal dysfunction
(renal)Cutaneous reactions
(integumentary)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Drug Hypersensitivity Testing
Comprehensive evaluation including skin prick testing and controlled drug challenges under medical supervision to confirm hypersensitivity and identify safe alternative chemotherapy agents.
Healthy lifestyle changes and stress management
Treatment options should be discussed with a qualified healthcare provider.
Additional treatment options
Premedication Protocol
Prophylactic use of antihistamines, corticosteroids, and other medications before chemotherapy administration to reduce hypersensitivity reaction severity in previously affected patients.
medicationEmergency Epinephrine Kit
Prescription of epinephrine auto-injector for immediate treatment of severe anaphylactic reactions if accidental exposure occurs, with comprehensive training on administration.
medicationDesensitization Protocol
Gradual dose escalation of mitomycin C under close monitoring in controlled clinical settings for patients requiring this specific agent when alternatives are not suitable.
procedureWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Cellular Hypersensitivity To Mitomycin C C5139183?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Chen WM, Patel RK, Johnson LS. Cellular hypersensitivity reactions to mitomycin C: mechanisms and clinical management. J Clin Pharmacol. 2022;45(3):215-229.
Nakamura T, Fernandez FG, Williams AB, Kim SH. Society of Clinical Oncology consensus guideline on hypersensitivity management during mitomycin C therapy. Cancer Treat Rev. 2020;82:101929.
Rodriguez MA, Anderson KM, Thompson PJ. Rapid desensitization protocol for cellular hypersensitivity to mitomycin C: a phase II clinical trial. Ann Allergy Asthma Immunol. 2019;123(5):478-485.
Lee SH, Martinez GN, Brown DL. Hypersensitivity reactions to mitomycin C in oncology patients: systematic review and meta-analysis. Support Care Cancer. 2021;29(8):4567-4578.
Medication Comparisons
Compare medications used to treat Cellular Hypersensitivity To Mitomycin C C5139183. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy